The goal of this study was to evaluate the influence of natural variation in the regenerative status of dog tissues on the signs of hormesis, which are evident after total body exposure to low daily doses of external gamma radiation throughout the lifespan. Ninety beagle dogs of both sexes were irradiated with cobalt 60 at 0.003 Gy/day commencing 1 year after birth to death. Control (n = 169) and irradiated animals underwent whole-life clinical observation and autopsy, and were then retrospectively divided into two subgroups with (W) or without benign tumors or tumors of unknown nature (WO) that were clinically recorded on single days throughout the lifespan. Radiation hormesis was only detected in subgroup WO, which had life span (LS) of 10.7 years in the absence of radiation. The radiogenic prolongation of life to 11.8 years in the WO subgroup (p < 0.05) was similar to that in the W control and irradiated W subgroups (11.8 and 11.5 years, respectively). The number of solid malignancies found upon autopsy of the control WO subgroup was less (39.5%) than that evident in the control W subgroup (60%). Compared to the irradiated W subgroup, irradiation of the WO subgroup was accompanied by a slight increase (1.14-fold) in the number of solid malignancies evident at autopsy and in the clinical signs of tissue atrophy and body weight loss (2.4-fold and 2.4-fold, respectively), but was accompanied by strong reductions in the extent of anemia and hemoblastoses (>10-fold for both). The data exclude the notion that radiation is associated with healing, but suggest that certain pathologies (e.g., hemoblastoses) may be substituted with other less dangerous somatic diseases in weaker animals only.
Introduction
Studies on high-level natural background radiation, occupational exposure, and life in radon-containing environments have suggested that low-dose radiation has a hormetic effect (a biphasic dose-response with an optimum health index of about 0.000014 Gy/day). Earlier studies considered mortality from cancer, overall growth, life span (LS), and tissue regeneration capacity in this context [1] [2] .
Recently, radiation hormesis has been considered a form of useful cancer therapy when total-body irradiation (TBI) is delivered to a cumulative dose of 1.5 Gy at about 0.1 Gy/day [3] . Many studies have attributed hormesis to potentiation of the immune system [1] - [8] . Any reported potentiation/stimulation conflicts with the tenets of the linear no-threshold (LNT) model, which emphasizes the harmful biological effects of radiation. Fliedner et al. [9] calculated that irradiation at 0.000014 and 0.1 Gy/day caused every cell in the body to stochastically receive either 0.05 of an event of average energy deposition (a hit)/day or more than 360 such events/day. It is difficult to explain the supposed immunopotentiation afforded by such a difference (≈10 A recent radical statement, "the LNT [model] needs to be discarded and afforded the same credibility as Lysenkoism," [10] has triggered scientific confrontation.
Such confrontation would be less radical if hormesis was not caused by radiation-mediated stimulation, but rather, by radiation injury. Such a possibility has recently been rendered plausible by reports on changes in trophic and morphogenic properties upon renewal of rapidly proliferating tissues (both normal and malignant) attributable to the actions of special subsets of circulating hemopoietic stem and progenitor cells from the bone marrow (BM) and thymus, which enhanced the proliferation in tissues of other histotypes [11] - [17] . These data confirmed that the hemopoietic system exhibited a trophic (feeding) function, posing challenges to the assumptions of many models based on previously accepted notions of cellular immune defense. For example, if feeding is important, it is easy to explain why myelosuppression is beneficial during cancer treatment [18] . The novel idea also explains why the instantaneous rates of death from cancer decline, although the instantaneous rates of mortality from non-malignant and infectious diseases increase during age-dependent immune system involution [19] [20] . In addition, dogs exhibiting clinical signs of tissue hyperproliferation (either benign or of unknown nature) live longer, and are more radioresistant, because their BM constitutes a more potent proliferative resource [21] .
Enhancement of cancer patient survival after short-term TBI or subtotal body irradiation (sTBI), delivered at cumulative doses of 11 and 1.9 Gy [12] [22] [23] [24], is a typical initial (positive) example of a biphasic hormetic reaction. Such doses are inadequate to directly control tumor growth, being 3 -30-fold lower than the minimal doses used in conventional local radiation therapy [25] [26] .
Nevertheless, both TBI and sTBI indirectly retard cancer progression by reducing the numbers of circulating feeding cells and enhancing the lymphocytopenic grade. Deep lymphocytopenia is an officially recognized form of cancer therapy [27] . angiogenic T-lymphocytes, and certain other "regulatory" cells [17] [28] [29] . As most such cells are more radiosensitive than mature cells, high doses of radiation or cytotoxic anticancer drugs may weaken stimulation by such cells of tumor growth. At the lowest doses (1 -1.5 Gy) of TBI or sTBI, most sub-lethally injured normal cells may successfully compete with a relatively small pool of malignant targets, encouraging migratory feeding cells to repair/regenerate areas other than tumor tissues [30] . Such competition between tissues may delay cancer progression even in the absence of any quantitative changes in the principal subpopulations of blood cells, which are typically not evident at whole-of-life irradiation doses ≤ 0.003 Gy/day [9] . If malignant progression depends on cellular proliferative potency more than on anticipated anticancer immunity, interesting questions arise: How long will stimulation of anticancer immunity dominate the explanation of how hormetic phenomena influence the LS? How long will the radiation hormesis model conflict with the non-threshold hypothesis of radiobiology? To answer these questions, we need to know how hormesis varies with the tissue-renewal status of irradiated normal subjects. If the effects of radiation hormesis in terms of the LS are accompanied by loss of somatic viability, hormesis cannot be interpreted as stimulating immunity and vice versa. The appropriate radiation dose during such a protracted period must align with the "tolerance dose" concept [31] . Such a dose, which spares all of the principal blood cell parameters during chronic irradiation [9] , was used in this study. The purpose of this retrospective work was to evaluate and compare the beneficial and negative influences of whole-of-life total-body gamma irradiation on the health of dogs in terms of LS, development of malignancy, instantaneous death hazard, development of principal clinical symptoms, and pathological status, by the regenerative capacities of various tissue types.
Methods
Animals. All of the data were derived in collaboration with Professor G. Woloschak, Northwestern University (Chicago, IL, USA). The Woloschak Laboratory hosts several radiobiology archives that contain data and tissues from radiobiological megastudies performed in the second half of the 20 th century, which were originally described by Carnes and Fritz (1993) . Data acquired by the Argonne National Laboratory (Lemont, IL, USA) were extracted from the "γ-Beagle Dog
Tissue Archive". We examined data stored as: "Life span: Whole Life Gamma Irradiation, External Co-60 gamma-ray exposure, continued until death on 13-month-old dogs of both sexes"
(http://janus.northwestern.edu/dog_tissues/introduction.php). We analyzed the sections entitled "Clinical observations" and "Pathology observations," which contained data on 90 dogs of both sexes that had been originally randomized and irradiated with cobalt 60 gamma rays at 0.003 Gy/day for 22 h per day, 7 days a week, commencing at day 400 after birth and continuing until death. We also reviewed data on a control group of 169 animals (stored under: "Various
Groups from Stock, Breeders and so forth; group: 100. Colony control").
Subgroups. To evaluate hyperproliferative processes, both the control and ir- The two linear regions were characterized by initially slow death rates followed by later sharp rises. Both parts were separately fitted to exponential functions using the simplest possible equation:
where S was survival in relative units, t was the elapsed time in years, and k was the hazard rate (instantaneous death rate per year) [32] .
In addition to constructing survival curves based on hazard rates, survival was also investigated using the alternative subject-years method, whereby survival is presented as the instantaneous product (N × T) of the surviving members of a population (N) by the number of lived years (T) at a current time and age [33] . 
Terms. Each of the four subgroups was characterized using certain principal parameters (average LS, malignant solid tumor percentage, and percentages of malignant hemoblastoses and anemias evident clinically during the LS and upon final pathology). The percentages of additional abnormalities were also recorded. Fisher's exact test was used to explore statistical significance. Averages (M values) and standard error (SEs) were compared using the t-criterion, if necessary.
Results

1) Overview
The LS of the overall control (11.2 ± 0.3 years) and overall irradiated (11.7 ± 0.25 years) groups were identical (p = 0.19). The average principal parameters of various subgroups are shown in Table 1 . The proportions of both malignant hemoblastoses and anemias in the control WO and W subgroups were identical (11.5% and 13.6%, respectively), but the longer LS (11.8 years) of control W dogs was associated with a higher percentage (60%) of solid malignancies (carcinomas, adenocarcinomas) ( Table 1) together with more inflammation and tissue atrophy ( Table 2) . Radiation selectively extended the LS of subgroup WO (from 10.7 to 11.8 months), rendering the initial (control) difference between the two subgroups insignificant. Our preliminary data [21] showed a trend of LS towards improvement at a dose of 0.003 Gy/day but we did not discuss it till the present study. This appeared to be attributable to complete elimination by radiation of all of the cases of initial hemopoietic pathology (hemoblastoses and anemias), from 11.5% (control value) to 0% ( Table 1 ). The percentage of solid malignancies 2) Survival analysis as revealed by semi-logarithmic plotting Semi-logarithmic survival curves are compared in Figure 1 (a) and Figure   1 (b).
The instantaneous hazard rates (k values/year) for the exponential functions (Equation (1) are shown in Table 3 Figure 1(a) and Table 3 show that, in the control WO subgroup with a shorter LS, the hazard rate k 1 during the first part of life was 2.6-fold greater than that of subgroup W (0.072/year vs. 0.028/year). The principal reason may be that hematopoietic disorders were more prevalent in control WO animals (Table 1 ).
In the WO subgroup, irradiation was associated with obvious declines in the hazard rates k 1 (2.9-fold) and k 2 (1.5-fold). In the W subgroup, both k 1 and k 2 were also reduced, but only slightly (2.06-fold and 1.39-fold respectively) ( Figure 1 and Table 3 ). Thus, the most prominent hormetic decline was in the k 1 of the WO subgroup.
However, the zones between the two exponential regions (the "middle-age" zones 10 -13 years) of each curve of Figure 1 cannot be evaluated or quantitatively compared in this manner. A precise analysis follows.
3) Survival in terms of dog-years.
The plots are shown in Figure 2 hormesis is not a permanent, but rather, is a passing phenomenon that is most prevalent in WO animals with a basally reduced LS and fewer solid malignancies (Table 1) . Hormesis was principally in frail animals in whom irradiation triggered extensive atrophy and body weight loss (Table 4) , accompanied by almost complete elimination of hemopoietic abnormalities but a slight increase in the number of solid malignancies (Table 1) . 
Discussion
The speed and extent of regeneration/reparation in tissues dosed with 0.003
Gy/day preserved the LS in general populations of Beagle dogs [9] . We confirmed this conclusion in this study in which we focused on multiorgan injures developing after irradiation [35] . WO subgroups were assumed to include animals exhibiting stronger anti-cancer immunity than W subgroups. However, in practice, the control WO subgroup included weaker dogs with a shorter LS than W subgroup animals (Table 1) . Moreover, the greater extents of body weight loss and tissue atrophy in the irradiated WO subgroup (Table 4 ) defied initial expectations. By contrast, the control W subgroup had a longer LS despite the presence of more solid tumors ( Table 1 ). The greater extent of inflammation in this subgroup (Table 2 ) combined with the minimal loss of body weight upon irradiation ( (Table 1) .
Such a conclusion is in accordance with the data of Figure 3 . The right border of the cumulative dose inducing the hormetic phenomenon in WO animals was larger (14.8 Gy at 13.5 years) than that of W animals (13.1 Gy at 12 years).
Thus, the different effects of identical doses of radiation given to two subgroups of a single breed of dogs indicate that factors such as basal regenerative status influences radiation hormesis. The depth of injuries to normal tissues may differ in animals varying by health status, such as dogs of the WO and W subgroups. Health, n turn, is conditioned by proliferative myelopoiesis, and as such, the effects of a feeding cell numbers by their on the Hayflick's limit [38] . If this is the case, the data indicate that weaker (WO) animals are less able to produce morphogenic cells. Limited numbers of such cells trigger re-orientation them from privileged (quasi-embryonic) malignant growth toward urgent repair/ regeneration of the many injured somatic cells. Therefore, malignant proliferation is reduced, as evidenced by the reduced numbers of hemoblastoses in WO animals (Table 1) , effectively preserving longevity.
In W animals, the morphogenic hemopoietic resource appeared to be greater, and thus adequate to serve the continuing proliferative needs of both malignant growth and regeneration of multiple radiogenic injures to normal tissues, but without development of competition between these two processes triggered by exhaustion of the morphogeniс potential, as was evident in WO animals. The hormesis evident in the WO subgroup ( Figure 3 ) co-existed with a slight increase in the proportion of solid cancers ( [42] . Considering the absence of any hemopoietic pathology in the irradiated WO subgroup, recommitment of circulating feeding cells from contributing to potential hemoblastoses to repair of the many injured normal cells may explain the slight increase in the development of new solid malignancies, and also, the observed LS extension. Diversion of feeding cells from tumor development to repair/regeneration of many sublethally injured normal cells, including hemopoietic progenitors, was evident at low radiation doses inadequate to trigger myelosuppression [9] . This may partly explain why anemia was not noted in WO animals ( Table 1 ).
It is remarkable that the hormetically mediated life extension in the weaker WO subgroup did not exceed the LS typical of the healthier W subgroup (Table   1) , indicating again that no form of pure stimulation occurred. Moreover, hormesis declines with age. A natural (and abrupt) defect in the morphogenic potency of the hemopoietic system develops in dogs at about 10 years of age (Figures 1-3 ) [21] . At this time, thymus function ceases in dog breeds [43] . This This viewpoint does not recognize a general healing property of radiation, but rather, the partial substitution of one pathology (e.g., malignancy) by others (somatic diseases) that are less life threatening [9] [20].
Summary
The dependence of radiation hormesis on tissue regenerative status disproves the notion that hormesis is attributable to stimulation of antineoplastic immunity. Hormesis reflects the basal trophic influences of circulating cells of BM/ thymus origin on cellular renewal in both malignant and normal tissues; sublethal cellular radiation damage redirects hormetic activities to partially substitute one pathology (e.g., fatal blastoses) for others (somatic diseases) that are less lifethreatening. Recognition of a trophic axis: "lymphocytopoiesis-migrant morphogenic cells-renewal of organs and tissues" suggests that sublethal damage is actually required when hormesis occurs at low doses of radiation. This idea does not conflict with, and is actually closely related to, the concept of multiorgan injury after irradiation. In addition, it suggests that the notion of radiobiological "stimulation" is inappropriate, at least in mammals.
